Posted As the availability and sophistication of smart technology for health (such as wearables, sensors, and micro-robotic tools) continues to increase, these devices could prove transformative in cancer prevention. Two ongoing... Read More
POSTED: 09/08/2020
SOURCE: Cancer Prevention Science Blog
Regular Aspirin Use May Increase Older People’s Risk of Dying from Cancer
Numerous studies have suggested that people who regularly take low doses of aspirin may have reduced risks of being diagnosed with or dying from cancer. But new findings from a randomized clinical trial, called ASPREE,... Read More
POSTED: 08/18/2020
SOURCE: Cancer Currents Blog
RESEARCH UPDATE: ON THE CLINICAL FRONT Zinc Induces Potential Chemopreventive Activity in Barrett’s Esophagus Zinc’s chemopreventive activity for esophageal cancer has been well demonstrated in animal models. In humans,... Read More
POSTED: 07/30/2020
SOURCE: DCP News
Responding to Coronavirus, Cancer Researchers Reimagine Clinical Trials
When the coronavirus pandemic reached the United States, thousands of people with cancer were participating in clinical trials, including many at St. Jude Children’s Research Hospital in Memphis, Tennessee. At St. Jude,... Read More
POSTED: 06/29/2020
SOURCE: NCI Cancer Currents Blog
NIH scientists develop blood test to help improve liver cancer screening
Scientists have developed a new test that can help identify people who are likely to develop hepatocellular carcinoma (HCC), the most common form of liver cancer. The approach uses a simple blood test to check for the... Read More
POSTED: 06/11/2020
SOURCE: NCI Press Release
A new technology coupled with a new biomarker test now in clinical trials are giving patients timely access to a quick, accurate and less invasive way to identify risk for one type of esophageal cancer. EsoCheckâ„¢ and... Read More
POSTED: 06/01/2020
SOURCE: Cancer Prevention Science Blog
How Does COVID-19 Affect People with Cancer? NCCAPS Will Help Find Out
With the sudden explosion of the COVID-19 pandemic, we are all living with a great deal of fear, uncertainty, and anxiety. As an oncologist and cancer researcher, I know that those feelings are heightened for many people... Read More
POSTED: 05/21/2020
SOURCE: NCI Cancer Currents Blog
COVID-19 is an emerging, rapidly evolving situation. In addition to the information sources listed in the web header, the National Cancer Institute and the Division of Cancer Prevention have issued guidance for DCP... Read More
POSTED: 05/07/2020
SOURCE: DCP News
NCORP Partners in ACTIV Response to COVID-19
The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, the Health and Human Services Office of the Assistant Secretary for... Read More
POSTED: 05/04/2020
SOURCE: NIH Press Release
Updated: July 9, 2020 NCI participated in the American Association for Cancer Research (AACR) Annual Meetings, held virtually on April 27 -Â 28, 2020 (Meeting I) and June 22 -Â 24, 2020 (Meeting II), including presenting the... Read More
POSTED: 04/29/2020
SOURCE: DCP News
RESEARCH UPDATE: ON THE CLINICAL FRONT No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Polyps Vitamin D has been associated with lower incidence and mortality of colorectal cancer, yet... Read More
POSTED: 04/23/2020
SOURCE: DCP News
Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing Types
More than a decade after vaccination, women who had received a single dose of human papillomavirus (HPV) vaccine continued to be protected against cervical infection with the two cancer-causing HPV types targeted by the... Read More
POSTED: 04/10/2020
SOURCE: NCI Cancer Currents Blog
Women Experience More Side Effects from Pelvic Radiation than Realized
Women undergoing radiation therapy for cervical or uterine cancer have a much higher incidence of serious side effects than previously realized, according to results from a new clinical trial. This information may help women... Read More
POSTED: 04/08/2020
SOURCE: NCI Cancer Currents Blog
Experimental Drug Prevents Doxorubicin from Harming the Heart
The chemotherapy drug doxorubicin is used to treat many types of cancer, but some patients who receive the drug develop heart problems. Using new insights into how doxorubicin damages the heart, researchers have identified... Read More
POSTED: 04/06/2020
SOURCE: NCI Cancer Currents Blog
While researchers have identified some of the genetic changes that lead to cancer development, a key knowledge gap remains: finding the genetic changes that drive the development of cancers that arise at an earlier age than... Read More
POSTED: 03/05/2020
SOURCE: Cancer Prevention Science Blog
RESEARCH UPDATE: ON THE CLINICAL FRONT Genetic Variants May Partially Explain Response to Tomato Juice Intake in Men with Prostate Cancer Tomato product and lycopene intakes are associated with reduced prostate cancer risk... Read More
POSTED: 02/19/2020
SOURCE: DCP News
Cervical cancer is highly preventable, yet it is not fully prevented. Significant advancements in our understanding of the human papillomavirus (HPV)-linked development of cervical cancer have created highly effective... Read More
POSTED: 02/03/2020
SOURCE: Cancer Prevention Science Blog
In the path toward understanding the development and ultimate prevention of prostate cancer, researchers are studying how to keep low-grade, early stage prostate cancer being monitored on Active Surveillance from progressing... Read More
POSTED: 01/17/2020
SOURCE: Cancer Prevention Science Blog
Division of Cancer Prevention New Grantees with Acting DCP Division Director Dr. Debbie Winn (first row center). In November 2019, the NCI Division of Cancer Prevention (DCP) for the first time held a New Grantee Workshop... Read More
POSTED: 01/14/2020
SOURCE: DCP News
